Properties
Description
TZ9 targets the E2 enzymes involved in the ubiquitin-proteasome pathway, aiming to modulate protein degradation processes that are critical for various cellular functions and implicated in numerous diseases.
Molecular Formula
C17H14N6O4
Identity
Confirmed by NMR/HPLC/MS.
Applications
TZ9 is an E2 conjugating inhibitor employed to study protein ubiquitination pathways and their applications in therapeutic development.
